Drug Patent Expirations in February 2010

*Drugs may be covered by multiple patents

Tradename	Applicant	Generic Name	Patent Number	Patent Expiration
ZAGAM	Mylan	sparfloxacin	4,795,751	Feb 4, 2010
TEVETEN	Abbott	eprosartan mesylate	5,185,351	Feb 9, 2010
MYOVIEW	Ge Healthcare	technetium tc-99m tetrofosmin kit	5,045,302	Feb 9, 2010
TEVETEN HCT	Abbott	eprosartan mesylate; hydrochlorothiazide	5,185,351	Feb 9, 2010
HYZAAR	Merck	hydrochlorothiazide; losartan potassium	5,138,069*PED	Feb 11, 2010
COZAAR	Merck	losartan potassium	5,138,069*PED	Feb 11, 2010
EXUBERA	Pfizer	insulin recombinant human	RE37872	Feb 12, 2010
EXUBERA	Pfizer	insulin recombinant human	RE38385	Feb 12, 2010
MEPRON	Glaxosmithkline	atovaquone	4,981,874*PED	Feb 15, 2010
NITRO-DUR	Key Pharms	nitroglycerin	5,186,938	Feb 16, 2010
SANDIMMUNE	Novartis	cyclosporine	7,511,014	Feb 16, 2010
ALDARA	Graceway	imiquimod	4,689,338*PED	Feb 25, 2010